Why is SMS Pharma. falling/rising?

As of 10-Jul, SMS Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 237.05, which reflects a decrease of 0.45 or 0.19%. The stock has been underperforming recently, having fallen consecutively for the last four days, resulting in a total decline of 2.85% during this period. Despite outperforming its sector by 0.38% today, the stock's performance over the past week shows a decrease of 0.73%, while its one-month return is down by 5.37%. The company has reported positive results for the last nine consecutive quarters, with significant metrics such as the highest operating profit to interest ratio and cash equivalents. However, the stock's long-term growth prospects appear weak, with net sales and operating profit growth rates of only 13.70% and 12.53%, respectively, over the last five years. Additionally, the increase in pledged promoter shares adds downward pressure on the stock.
In the broader market context, the Sensex has shown a slight decline of 0.06% over the past week, contrasting with SMS Pharmaceuticals' more significant drop. While the stock has generated a negative return of 4.80% over the past year, the benchmark has increased by 4.09%, indicating a notable underperformance relative to the market. The stock's liquidity remains adequate, but the falling investor participation, evidenced by a 23.33% decrease in delivery volume, suggests waning interest among investors. Overall, while the company has solid fundamentals, the combination of poor long-term growth prospects and increasing pledged shares is contributing to the stock's recent decline.